Search results
Matthew Perry’s death investigation: Here’s what we know
The Independent via Yahoo News· 1 day agoThe coroner noted that the ketamine in Matthew’s system “could not be from that infusion therapy,...
Here's How Much a $1000 Investment in ResMed Made 10 Years Ago Would Be Worth Today
Zacks via Yahoo Finance· 8 hours agoThis includes out-of-hospital software platforms designed to support professionals and caregivers...
... Patient Care While Easing Operational Demands With Rehab Therapy’s First AI-Integrated EMR |...
Healthcare Dive· 14 hours agoFrom front desk operations to back office billing, SPRY Ally shortens time-intensive processes such as securing and verifying patient insurance and obtaining pre-authorization approval for treatment ...
Google DeepMind CEO: ‘This Is the Next $100 Billion AI Business’
InvestorPlace via Yahoo Finance· 6 days agoThese days, AI stocks are all the rage – and with good reason. We believe that as its underlying...
Needham & Company LLC Reaffirms Buy Rating for Autolus Therapeutics (NASDAQ:AUTL)
ETF DAILY NEWS· 4 days agoNeedham & Company LLC reaffirmed their buy rating on shares of Autolus Therapeutics (NASDAQ:AUTL – Free Report) in a research note released on Friday, Benzinga reports. They ...
Edward L. Kuntz Sells 2,500 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) Stock
ETF DAILY NEWS· 6 days agoU.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) Director Edward L. Kuntz sold 2,500 shares of U.S. Physical Therapy stock in a transaction that ...
After Pegasus Was Blacklisted, Its CEO Swore Off Spyware. Now He’s the King of Israeli AI.
The Intercept· 1 hour agoShalev Hulio, once dubbed “Israel’s cyber bad boy,” has been working hard to remake himself. Things...
Pulmatrix (NASDAQ:PULM) Share Price Crosses Above 50 Day Moving Average of $1.87
ETF DAILY NEWS· 6 days agoPulmatrix, Inc. (NASDAQ:PULM – Get Free Report) passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $1.87 and traded as high as $1.98 ...
Opaleye Management Inc. Sells 70,885 Shares of Protara Therapeutics, Inc. (NASDAQ:TARA) Stock
ETF DAILY NEWS· 5 days agoProtara Therapeutics, Inc. (NASDAQ:TARA – Get Free Report) major shareholder Opaleye Management Inc. sold 70,885 shares of the firm’s stock in a transaction dated Friday, May 17th. The shares ...
RAPT Therapeutics (NASDAQ:RAPT) Stock Rating Reaffirmed by Wolfe Research
ETF DAILY NEWS· 6 days agoWolfe Research reissued their peer perform rating on shares of RAPT Therapeutics (NASDAQ:RAPT – Free Report) in a research note issued to investors on Tuesday, Marketbeat.com ...